1 to stronger opioids when pain control is the
primary objective.
2 in autism spectrum disorders (ASDs) with two
primary objectives.
3 A-IIIC) met the eligibility criteria for the
primary objective analysis, with an additional 22 patien
4 ate the effect of atorvastatin on HIV-1 RNA (
primary objective)
and cellular markers of immune activa
5 primary endpoint was broken up into three co-
primary objectives:
disease-free survival in the overall
6 The study met the
primary objective efficacy ICSS end point in demonstrati
7 The
primary objective efficacy measure (sign) was mean chang
8 This study's
primary objective examined the relationship between GSK2
9 for marginal association, which is often the
primary objective in inference, rather than the main eff
10 Our
primary objective in this exploratory study was to ident
11 control over crystal structure is one of the
primary objectives in crystal growth, the present lack o
12 The
primary objective included analysis of geometric mean ti
13 In the setting of PCR, the
primary objective is the safe and thorough evacuation of
14 In this study, our
primary objective is to develop a Bayesian hierarchical
15 The
primary objective is to evaluate histologically and hist
16 The
primary objective is to evaluate superiority of the prop
17 The
primary objective is to investigate the safety and toler
18 noted with eltrombopag and the trial met the
primary objective of a reduction in CRTEs; eltrombopag m
19 The
primary objective of acoustic metamaterial research is t
20 Although the presumption is often that the
primary objective of asking for family consent is to sec
21 ntaining optimal symptom control remains the
primary objective of asthma treatment.
22 The
primary objective of Children's Oncology Group study P96
23 progression, both in routine care and as the
primary objective of clinical trials.
24 particles, understanding that structure is a
primary objective of condensed matter research.
25 The study did not meet its
primary objective of demonstrating that fludrocortisone
26 Here, we compare arms A and C, with the
primary objective of establishing whether overall surviv
27 nce, the targeted chemical production is the
primary objective of MOMAKnock while the MOMA assumption
28 ntrolling nutrient levels in watersheds is a
primary objective of most environmental policy.
29 The
primary objective of noninferiority of the humoral immun
30 The
primary objective of noninferiority was met: 7 patients
31 The
primary objective of our study was to determine whether
32 Therefore, the
primary objective of our study was to screen for differe
33 The study met its
primary objective of PFS prolongation with vandetanib ve
34 Although the
primary objective of reducing the proportion of subjects
35 ERPRETATION: The GOLD study did not meet its
primary objective of showing a significant improvement i
36 Designing tight-binding ligands is a
primary objective of small-molecule drug discovery.
37 The study did not meet the
primary objective of statistically significant improveme
38 The
primary objective of such a device is to see if addition
39 3%, 95% confidence interval 76%-91%) met the
primary objective of superiority versus the historical c
40 The
primary objective of the AA5208/OCTANE trial was to comp
41 The
primary objective of the appropriate use criteria is to
42 The
primary objective of the AUC is to provide a framework f
43 The
primary objective of the decision process is to identify
44 The
primary objective of the INFORM trial was to assess all-
45 The
primary objective of the KEYNOTE-001 trial was to assess
46 The
primary objective of the Lessons From Antagonizing the C
47 The
primary objective of the phase III part of this study wa
48 Thus, the
primary objective of the present study was to determine
49 The
primary objective of the research was to determine wheth
50 The
primary objective of the study was to assess the safety
51 The
primary objective of the study was to calculate prevalen
52 The
primary objective of the study was to compare the effect
53 The
primary objective of the study was to determine whether
54 The
primary objective of the study was to evaluate the overa
55 sound for dengue fever screening; hence, the
primary objective of the study was to evaluate the utili
56 trial), but only the AZA group fulfilled the
primary objective of the study.
57 The
primary objective of the TAVR-LM registry is to evaluate
58 The
primary objective of the trial was defined as evaluation
59 ons to this nested cohort study are that the
primary objective of the trial was designed to measure e
60 The
primary objective of the trial was event-free survival (
61 The
primary objective of these two trials was to determine t
62 A
primary objective of this article was to provide a gener
63 An important
primary objective of this council is to define the essen
64 The
primary objective of this international, multicenter, mu
65 The
primary objective of this international, pivotal, single
66 The
primary objective of this mechanistic open-label, strati
67 The
primary objective of this multicenter registry was to st
68 The
primary objective of this paper was to identify how fore
69 The
primary objective of this project was to decrease comput
70 The
primary objective of this project was to determine the a
71 The
primary objective of this prospective, randomized, doubl
72 The
primary objective of this randomized trial was to compar
73 The
primary objective of this retrospective analysis was to
74 The
primary objective of this study is to compare the preval
75 The
primary objective of this study is to determine at what
76 The
primary objective of this study is to dimensionally and
77 The
primary objective of this study is to histologically eva
78 The
primary objective of this study is to histologically eva
79 The
primary objective of this study is to investigate microb
80 The
primary objective of this study is to investigate the ex
81 The
primary objective of this study is to use histomorphomet
82 Primary objective of this study was the comparison of so
83 The
primary objective of this study was to assess the change
84 The
primary objective of this study was to assess the effect
85 The
primary objective of this study was to assess the status
86 The
primary objective of this study was to compare antibody
87 The
primary objective of this study was to compare the biodi
88 The
primary objective of this study was to compare the survi
89 The
primary objective of this study was to describe and asse
90 The
primary objective of this study was to determine if thes
91 The
primary objective of this study was to determine outcome
92 The
primary objective of this study was to determine whether
93 The
primary objective of this study was to determine whether
94 Primary objective of this study was to determine whether
95 The
primary objective of this study was to develop an image-
96 The
primary objective of this study was to elucidate mechani
97 The
primary objective of this study was to establish endotyp
98 The
primary objective of this study was to evaluate a range
99 The
primary objective of this study was to evaluate the asso
100 The
primary objective of this study was to evaluate the asso
101 The
primary objective of this study was to evaluate the caus
102 The
primary objective of this study was to evaluate the low-
103 The
primary objective of this study was to evaluate the phys
104 The
primary objective of this study was to evaluate the repr
105 The
primary objective of this study was to evaluate the resp
106 The
primary objective of this study was to evaluate the safe
107 The
primary objective of this study was to evaluate the safe
108 The
primary objective of this study was to examine the nutri
109 The
primary objective of this study was to find a mechanisti
110 The
primary objective of this study was to identify factors
111 The
primary objective of this study was to identify which pa
112 The
primary objective of this study was to investigate five
113 The
primary objective of this study was to obtain insights i
114 The
primary objective of this study was to test whether para
115 The
primary objective of this study was to use propensity sc
116 The
primary objective of this study was to utilize MR molecu
117 This was the
primary objective of this study, attained through two sp
118 for a correction of overlapping peaks is the
primary objective of this study.
119 The
primary objective of this systematic review and meta-ana
120 The
primary objective of this trial was to evaluate safety o
121 ta for the phase 1 portion of the study, the
primary objective of which was to establish the recommen
122 ociated independent monitoring strategy, the
primary objective of which was verification that tOPV wa
123 One of the
primary objectives of early visual processing is the det
124 relative protein quantification, one of the
primary objectives of mass spectrometry based proteomics
125 One of the
primary objectives of the intensive campaign was to inve
126 The
primary objectives of the study were to assess safety an
127 Therefore, the two
primary objectives of this investigation were to charact
128 The
primary objectives of this study were to describe the fr
129 The
primary objectives of this systematic review on oncoplas
130 The
primary objectives of this trial were to determine safet
131 eport the prespecified final analysis of the
primary objectives,
OS and adverse events.
132 but if particulate matter reductions are the
primary objective,
other approaches to time-differentiat
133 The model's discrimination for the
primary objective performed better than the European Gro
134 End points included safety (
primary), objective response rate, and overall survival
135 -forming units) were required to achieve the
primary objective,
resulting in attack rates of 55% (11/
136 Safety was the
primary objective;
secondary objectives included standar
137 tional longitudinal studies, having as their
primary objective the creation of postnatal growth chart
138 For the
primary objective,
the gingival thickness that best corr
139 The study met its
primary objective to demonstrate the superiority of CE o
140 Bangladesh, were enrolled in a study with a
primary objective to establish noninferiority of concomi
141 0 is a prospective, multicenter study with a
primary objective to evaluate the diagnostic accuracy of
142 The
primary objective (
to determine the maximum tolerated do
143 The
primary objective was 1-year event-free survival (EFS) a
144 Our
primary objective was a comprehensive re-estimation of d
145 The part 2
primary objective was assessed by a composite primary en
146 The
primary objective was assessment of antitumor activity u
147 Primary objective was assessment of patient discomfort i
148 The
primary objective was assessment of safety; secondary en
149 The
primary objective was comparison of PFS between the two
150 The
primary objective was comparison of the proportion of pa
151 The
primary objective was complete response (CR).
152 The
primary objective was DFS in patients with ER-positive B
153 The
primary objective was feasibility, defined as the propor
154 The
primary objective was identifying the number of patients
155 The
primary objective was met in both treatment arms.
156 The
primary objective was mortality after subarachnoid hemor
157 Although the
primary objective was not met, subgroup analyses showed
158 The
primary objective was overall and complete response rate
159 The
primary objective was prediction of overall mortality (O
160 The
primary objective was product-related AEs.
161 The
primary objective was progression-free survival in the i
162 The
primary objective was recurrence-free survival (RFS), an
163 The
primary objective was response rate in patients with thy
164 The
primary objective was safety (incidence of adverse event
165 The
primary objective was safety and immunogenicity of the Z
166 The
primary objective was safety and tolerability 28 days po
167 The
primary objective was safety and tolerability of RG-101.
168 The
primary objective was safety and tolerability of the com
169 The
primary objective was safety and tolerability, with seve
170 The
primary objective was safety evaluation.
171 The
primary objective was safety, including antibody testing
172 The
primary objective was the cumulative incidence of death,
173 The
primary objective was the healing of rickets, as assesse
174 The
primary objective was the major molecular response (MMol
175 The
primary objective was the rate of hematologic normalizat
176 The
primary objective was the vaccine effectiveness of at le
177 Our
primary objective was to assess feasibility and safety;
178 in insulin-resistant muscle are unknown, our
primary objective was to assess insulin-stimulated GU, p
179 Our
primary objective was to assess protective efficacy agai
180 The
primary objective was to assess safety and tolerability
181 The
primary objective was to assess safety and tolerability
182 The
primary objective was to assess safety and tolerability.
183 The
primary objective was to assess safety and tolerability.
184 The
primary objective was to assess safety at 12 weeks after
185 The
primary objective was to assess safety, tolerability, an
186 The
primary objective was to assess safety; secondary object
187 The
primary objective was to assess the clinical efficacy of
188 The
primary objective was to assess the effect of telaprevir
189 The
primary objective was to assess the effectiveness of TDF
190 The
primary objective was to assess the efficacy of the vacc
191 Our
primary objective was to assess the impact of mineraloco
192 The
primary objective was to assess the long-term safety pro
193 The
primary objective was to assess the safety and tolerabil
194 Our
primary objective was to assess the safety and tolerabil
195 The
primary objective was to assess the safety of self-admin
196 The
primary objective was to assess the superiority of bOPV-
197 Our
primary objective was to characterise product safety, an
198 TENOR's
primary objective was to characterize the natural histor
199 The
primary objective was to compare antirotavirus immunoglo
200 The
primary objective was to compare disease-free survival b
201 The
primary objective was to compare major adverse cardiovas
202 The
primary objective was to compare overall survival (OS) i
203 The
primary objective was to compare progression-free surviv
204 The
primary objective was to compare progression-free surviv
205 The
primary objective was to compare targeted and standard b
206 The
primary objective was to compare the number of patients
207 The
primary objective was to compare the tracheal sealing pe
208 Our
primary objective was to define the incidence of at leas
209 The
primary objective was to demonstrate improvement in prog
210 The
primary objective was to demonstrate noninferiority (10%
211 Primary objective was to demonstrate noninferiority of d
212 The
primary objective was to demonstrate noninferiority of t
213 The
primary objective was to demonstrate the clinical applic
214 The
primary objective was to demonstrate the superiority of
215 Our
primary objective was to design and test the efficacy ov
216 The
primary objective was to determine a recommended phase 2
217 The
primary objective was to determine fatty acid compositio
218 The
primary objective was to determine GED-0301's effect on
219 The
primary objective was to determine if ALC prevents CIPN
220 The
primary objective was to determine if colistin dose (mg
221 The
primary objective was to determine if wireless remote mo
222 Primary objective was to determine pharmacokinetics, saf
223 The
primary objective was to determine safety, toxicity, and
224 The
primary objective was to determine the difference in NK
225 Our
primary objective was to determine the dose-response rel
226 Primary objective was to determine the effect of AR per
227 In this study, our
primary objective was to determine the effect of timing
228 Our
primary objective was to determine the effect on risk of
229 The
primary objective was to determine the maximum tolerated
230 tients received 28-day treatment cycles; the
primary objective was to determine the maximum tolerated
231 The
primary objective was to determine the maximum tolerated
232 The
primary objective was to determine the overall response
233 The
primary objective was to determine the safety of the vac
234 The
primary objective was to determine the vascular effects
235 Our
primary objective was to determine whether adding GO to
236 Our
primary objective was to determine whether interleukin-1
237 Our
primary objective was to determine whether peanut OIT ca
238 Our
primary objective was to determine whether previous radi
239 The
primary objective was to determine whether programmed hi
240 The
primary objective was to determine whether spironolacton
241 The
primary objective was to determine whether vandetanib 10
242 The
primary objective was to develop a coupled exposure-dose
243 This study's
primary objective was to develop a procedure to measure
244 The
primary objective was to establish noninferiority of lap
245 The
primary objective was to establish the maximum tolerated
246 The
primary objective was to establish the safety and tolera
247 Our
primary objective was to estimate the proportion of all
248 The
primary objective was to estimate the toxicity contour o
249 st severe form of systemic inflammation, the
primary objective was to evaluate chronic pain states an
250 The
primary objective was to evaluate HPV-16/18 antibody res
251 The
primary objective was to evaluate overall survival at 1
252 The
primary objective was to evaluate the dose-response rela
253 The
primary objective was to evaluate the efficacy of citalo
254 The
primary objective was to evaluate the efficacy of omaliz
255 The
primary objective was to evaluate the feasibility of sur
256 Our
primary objective was to evaluate the outcomes of minima
257 In the phase 2 portion, the
primary objective was to evaluate the overall response r
258 The
primary objective was to evaluate the safety and determi
259 The
primary objective was to evaluate the safety and tolerab
260 Our
primary objective was to examine whether the interventio
261 The
primary objective was to explore the association between
262 Primary objective was to identify factors associated wit
263 Primary objective was to identify leukocyte subsets that
264 The
primary objective was to identify the maximum tolerated
265 The
primary objective was to identify the safety and tolerab
266 Our
primary objective was to investigate a biomarker driven
267 The
primary objective was to investigate the effect of the S
268 The
primary objective was to measure, for the first time, th
269 MAIN OUTCOMES MEASURES: The
primary objective was to show noninferiority of ranibizu
270 The
primary objective was to show superiority in progression
271 The
primary objective was to show superiority of QVA149 vers
272 The
primary objective was to test for an improvement in even
273 Our
primary objective was to test for associations of the us
274 The
primary objective was to test the ability of a laparosco
275 The
primary objective was to test the hypothesis that the me
276 The
primary objective was to test the hypothesis that the tr
277 ffectiveness of the HRV vaccination program (
primary objective)
was measured by comparing the inciden
278 The two
primary objectives were investigator-assessed progressio
279 The
primary objectives were MTD evaluation and response to R
280 The
primary objectives were overall response rate (ORR) by i
281 The
primary objectives were safety and tolerability.
282 Primary objectives were safety and tolerability.
283 The
primary objectives were safety in patients who received
284 The
primary objectives were safety, tolerability, characteri
285 The
primary objectives were the HZ/su vaccine response rate
286 The
primary objectives were to assess feasibility and safety
287 The
primary objectives were to assess the diversity, distrib
288 Primary objectives were to assess the safety and the max
289 Primary objectives were to assess the safety of rovalpit
290 Our
primary objectives were to assess the safety profile and
291 Methods The
primary objectives were to assess tolerability, pharmaco
292 Primary objectives were to assess whether low sFlt-1:PlG
293 In this study, our
primary objectives were to clone the fathead minnow (FHM
294 In the phase 1 dose-escalation portion, the
primary objectives were to determine the incidence of do
295 Primary objectives were to determine the maximum tolerat
296 The
primary objectives were to establish individual readers'
297 The
primary objectives were to establish the maximum tolerat
298 The
primary objectives were to estimate and compare the sens
299 The
primary objectives were to evaluate the safety of MVA an
300 Primary objectives were: confirmed prostate-specific ant